ATRA Report

Atara Biotherapeutics, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
9.02
Last session price
9.02
Price now
Currency: USD
Reporting currency: USD
ISIN: US0465131078
INN:
.

ATRA financial statements

* Numbers in thousands
Year
2014 2015 2016 2017 2018 2019 2020 TTM
Capitalization *
121 448 463 052 363 460 1 201 986 1 584 644 698 302 1 365 542 667 236
EV *
99 551 439 306 315 492 1 122 763 1 523 946 625 566 1 180 164 1 180 164
Stock price $
24.36 18.1 12.65 40.25 36.17 13.61 18.46 9.02
Number of shares *
4 986 25 583 28 732 29 863 43 811 51 308 73 973 73 973
EPS
-5,62 -2,24 -2,75 -4,00 -5,27 -5,67 -4,15 -4,15
Revenue *
0 0 0 0 0 0 0 0
Net income *
-28 006 -57 221 -79 049 -119 491 -230 699 -290 976 -306 620 -306 620
Operating profit *
-28 156 -58 448 -81 242 -121 532 -237 111 -295 681 -309 052 -309 052
Total liabilities *
2 940 9 875 10 178 39 915 52 982 52 161 125 781 125 781
Net debt *
-21 897 -23 746 -47 968 -79 223 -60 698 -58 600 -185 378 -185 378
Total assets *
106 122 324 975 263 914 217 779 391 839 342 942 588 120 588 120
Equity *
103 182 315 100 253 736 177 864 338 857 290 781 462 339 462 339
Cash and investments *
104 116 320 482 255 682 166 096 309 631 259 109 500 659 500 659

Over the past 10 years, the maximum capitalization of Atara Biotherapeutics, Inc. is 1 584 644, the minimum is 121 448.
Maximum net income 0, Minimum net income -306 620.
The maximum price of ATRA shares is 40.25, the minimum price is 12.65.

.

ATRA valuation

Year
2014 2015 2016 2017 2018 2019 2020 TTM
P/E
-4,34 -8,09 -4,60 -10,06 -6,87 -2,40 -4,45 -2,18
P/B
1,18 1,47 1,43 6,76 4,68 2,40 2,95 1,44
P/S
0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
E/P
-23% -12% -22% -10% -15% -42% -22% -46%
P/FCF
-7,28 -12,37 -5,77 -11,16 -7,35 -2,89 -7,37 -3,60
.

ATRA profitability

Year
2014 2015 2016 2017 2018 2019 2020 TTM
ROE
-27% -18% -31% -67% -68% -100% -66%
ROA
-26% -18% -30% -55% -59% -85% -52%
ROIC
-27% -19% -32% -64% -67% -97% -61%